In support of this statement, a subset of cancer patients undergoing radiotherapy will be retinoic acid-deficient [29] and subject to cellular and molecular mechanisms (e.g., deficient ATM activation, reduced stem cell differentiation, loss of tumor suppressor activity) that regulate carcinogenesis in a retinoic acid-sensitive fashion. Here, ATM is linked to neoplasm.